Skip to main content
Equibles

MetLife Investment Management, LLC

Position in NUVB — Nuvation Bio Inc.

CIK 1529735 Whippany, NJ
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$841,185
+$292,443 QoQ
Shares Held
148,096
+15.8% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. NUVB ranks #92 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in NUVB

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $841,185 148,096
2026-03-31 $548,742 127,912
2025-12-31 $1,238,074 138,178
2025-09-30 $547,085 147,861
2025-06-30 $300,356 154,029
2025-03-31 $157,229 89,335
2024-12-31 $275,701 103,647
2024-09-30 $208,506 91,051
2024-06-30 $308,579 105,678
2024-03-31 $310,823 85,391
2023-12-31 $119,724 79,288
2023-09-30 $106,245 79,288
2023-06-30 $142,718 79,288
2023-03-31 $110,044 66,292
2022-12-31 $82,152 42,788
2022-09-30 $145,239 64,839
2022-06-30 $210,078 64,839
2022-03-31 $471,690 89,675
2021-12-31 $490,450 57,700
2021-09-30 $253,976 25,551
2021-06-30 $158,214 16,994